Global Swine Vaccines Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Swine Vaccines market size was valued at US$ 1349.2 million in 2023. With growing demand in downstream market, the Swine Vaccines is forecast to a readjusted size of US$ 1793.4 million by 2030 with a CAGR of 4.1% during review period.
The research report highlights the growth potential of the global Swine Vaccines market. Swine Vaccines are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Swine Vaccines. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Swine Vaccines market.
The immune system responds by producing antibodies that destroy the infectious agents, usually in co-operation with specialised body cells or by neutralising the toxins that are responsible for the disease. This process of stimulating immunity is called vaccination.
Vaccines contain antigens from viruses, bacteria, bacterial toxins, or parasites. They are given to pigs, usually by injection, to stimulate an immune response which will protect the pigs against later natural infection with the organism from which the vaccine was derived. Most stimulate both a humoral response and a cell-mediated response.
Vaccines can either contain viable organisms that will multiply in the pig, or inactivated ones that will not multiply in the pig.
China is the largest region of Swine Vaccines, with a share more than 40%, followed by Europe and North America, etc. Merck, Boehringer Ingelheim, Jinyu Bio-Technology, CAHIC and Tecon are the top 5 manufacturers of industry, and they had a more than 55% combined market share.
Key Features:
The report on Swine Vaccines market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Swine Vaccines market. It may include historical data, market segmentation by Type (e.g., CSF Vaccines, FMD Vaccines), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Swine Vaccines market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Swine Vaccines market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Swine Vaccines industry. This include advancements in Swine Vaccines technology, Swine Vaccines new entrants, Swine Vaccines new investment, and other innovations that are shaping the future of Swine Vaccines.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Swine Vaccines market. It includes factors influencing customer ' purchasing decisions, preferences for Swine Vaccines product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Swine Vaccines market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Swine Vaccines market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Swine Vaccines market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Swine Vaccines industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Swine Vaccines market.
Market Segmentation:
Swine Vaccines market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
What is the 10-year outlook for the global Swine Vaccines market?
What factors are driving Swine Vaccines market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Swine Vaccines market opportunities vary by end market size?
How does Swine Vaccines break out type, application?
According to our LPI (LP Information) latest study, the global Swine Vaccines market size was valued at US$ 1349.2 million in 2023. With growing demand in downstream market, the Swine Vaccines is forecast to a readjusted size of US$ 1793.4 million by 2030 with a CAGR of 4.1% during review period.
The research report highlights the growth potential of the global Swine Vaccines market. Swine Vaccines are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Swine Vaccines. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Swine Vaccines market.
The immune system responds by producing antibodies that destroy the infectious agents, usually in co-operation with specialised body cells or by neutralising the toxins that are responsible for the disease. This process of stimulating immunity is called vaccination.
Vaccines contain antigens from viruses, bacteria, bacterial toxins, or parasites. They are given to pigs, usually by injection, to stimulate an immune response which will protect the pigs against later natural infection with the organism from which the vaccine was derived. Most stimulate both a humoral response and a cell-mediated response.
Vaccines can either contain viable organisms that will multiply in the pig, or inactivated ones that will not multiply in the pig.
China is the largest region of Swine Vaccines, with a share more than 40%, followed by Europe and North America, etc. Merck, Boehringer Ingelheim, Jinyu Bio-Technology, CAHIC and Tecon are the top 5 manufacturers of industry, and they had a more than 55% combined market share.
Key Features:
The report on Swine Vaccines market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Swine Vaccines market. It may include historical data, market segmentation by Type (e.g., CSF Vaccines, FMD Vaccines), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Swine Vaccines market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Swine Vaccines market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Swine Vaccines industry. This include advancements in Swine Vaccines technology, Swine Vaccines new entrants, Swine Vaccines new investment, and other innovations that are shaping the future of Swine Vaccines.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Swine Vaccines market. It includes factors influencing customer ' purchasing decisions, preferences for Swine Vaccines product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Swine Vaccines market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Swine Vaccines market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Swine Vaccines market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Swine Vaccines industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Swine Vaccines market.
Market Segmentation:
Swine Vaccines market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
- CSF Vaccines
- FMD Vaccines
- Porcine Circovirus Vaccines
- PRRS Vaccines
- Others
- Government Tender
- Market Sales
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Merck
- Boehringer Ingelheim
- Jinyu Bio-Technology
- CAHIC
- Tecon
- Zoetis
- Ceva
- Hile Bio
- Chopper Biology
- WINSUN
- Hipra
- Ringpu Biology
- ChengDu Tecbond
- DHN
- CAVAC
- Virbac
- HVRI
- Bioveta
What is the 10-year outlook for the global Swine Vaccines market?
What factors are driving Swine Vaccines market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Swine Vaccines market opportunities vary by end market size?
How does Swine Vaccines break out type, application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Swine Vaccines Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Swine Vaccines by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Swine Vaccines by Country/Region, 2019, 2023 & 2030
2.2 Swine Vaccines Segment by Type
2.2.1 CSF Vaccines
2.2.2 FMD Vaccines
2.2.3 Porcine Circovirus Vaccines
2.2.4 PRRS Vaccines
2.2.5 Others
2.3 Swine Vaccines Sales by Type
2.3.1 Global Swine Vaccines Sales Market Share by Type (2019-2024)
2.3.2 Global Swine Vaccines Revenue and Market Share by Type (2019-2024)
2.3.3 Global Swine Vaccines Sale Price by Type (2019-2024)
2.4 Swine Vaccines Segment by Application
2.4.1 Government Tender
2.4.2 Market Sales
2.5 Swine Vaccines Sales by Application
2.5.1 Global Swine Vaccines Sale Market Share by Application (2019-2024)
2.5.2 Global Swine Vaccines Revenue and Market Share by Application (2019-2024)
2.5.3 Global Swine Vaccines Sale Price by Application (2019-2024)
3 GLOBAL SWINE VACCINES BY COMPANY
3.1 Global Swine Vaccines Breakdown Data by Company
3.1.1 Global Swine Vaccines Annual Sales by Company (2019-2024)
3.1.2 Global Swine Vaccines Sales Market Share by Company (2019-2024)
3.2 Global Swine Vaccines Annual Revenue by Company (2019-2024)
3.2.1 Global Swine Vaccines Revenue by Company (2019-2024)
3.2.2 Global Swine Vaccines Revenue Market Share by Company (2019-2024)
3.3 Global Swine Vaccines Sale Price by Company
3.4 Key Manufacturers Swine Vaccines Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Swine Vaccines Product Location Distribution
3.4.2 Players Swine Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR SWINE VACCINES BY GEOGRAPHIC REGION
4.1 World Historic Swine Vaccines Market Size by Geographic Region (2019-2024)
4.1.1 Global Swine Vaccines Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Swine Vaccines Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Swine Vaccines Market Size by Country/Region (2019-2024)
4.2.1 Global Swine Vaccines Annual Sales by Country/Region (2019-2024)
4.2.2 Global Swine Vaccines Annual Revenue by Country/Region (2019-2024)
4.3 Americas Swine Vaccines Sales Growth
4.4 APAC Swine Vaccines Sales Growth
4.5 Europe Swine Vaccines Sales Growth
4.6 Middle East & Africa Swine Vaccines Sales Growth
5 AMERICAS
5.1 Americas Swine Vaccines Sales by Country
5.1.1 Americas Swine Vaccines Sales by Country (2019-2024)
5.1.2 Americas Swine Vaccines Revenue by Country (2019-2024)
5.2 Americas Swine Vaccines Sales by Type
5.3 Americas Swine Vaccines Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Swine Vaccines Sales by Region
6.1.1 APAC Swine Vaccines Sales by Region (2019-2024)
6.1.2 APAC Swine Vaccines Revenue by Region (2019-2024)
6.2 APAC Swine Vaccines Sales by Type
6.3 APAC Swine Vaccines Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Swine Vaccines by Country
7.1.1 Europe Swine Vaccines Sales by Country (2019-2024)
7.1.2 Europe Swine Vaccines Revenue by Country (2019-2024)
7.2 Europe Swine Vaccines Sales by Type
7.3 Europe Swine Vaccines Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Swine Vaccines by Country
8.1.1 Middle East & Africa Swine Vaccines Sales by Country (2019-2024)
8.1.2 Middle East & Africa Swine Vaccines Revenue by Country (2019-2024)
8.2 Middle East & Africa Swine Vaccines Sales by Type
8.3 Middle East & Africa Swine Vaccines Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Swine Vaccines
10.3 Manufacturing Process Analysis of Swine Vaccines
10.4 Industry Chain Structure of Swine Vaccines
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Swine Vaccines Distributors
11.3 Swine Vaccines Customer
12 WORLD FORECAST REVIEW FOR SWINE VACCINES BY GEOGRAPHIC REGION
12.1 Global Swine Vaccines Market Size Forecast by Region
12.1.1 Global Swine Vaccines Forecast by Region (2025-2030)
12.1.2 Global Swine Vaccines Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Swine Vaccines Forecast by Type
12.7 Global Swine Vaccines Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck Swine Vaccines Product Portfolios and Specifications
13.1.3 Merck Swine Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 Boehringer Ingelheim
13.2.1 Boehringer Ingelheim Company Information
13.2.2 Boehringer Ingelheim Swine Vaccines Product Portfolios and Specifications
13.2.3 Boehringer Ingelheim Swine Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Boehringer Ingelheim Main Business Overview
13.2.5 Boehringer Ingelheim Latest Developments
13.3 Jinyu Bio-Technology
13.3.1 Jinyu Bio-Technology Company Information
13.3.2 Jinyu Bio-Technology Swine Vaccines Product Portfolios and Specifications
13.3.3 Jinyu Bio-Technology Swine Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Jinyu Bio-Technology Main Business Overview
13.3.5 Jinyu Bio-Technology Latest Developments
13.4 CAHIC
13.4.1 CAHIC Company Information
13.4.2 CAHIC Swine Vaccines Product Portfolios and Specifications
13.4.3 CAHIC Swine Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 CAHIC Main Business Overview
13.4.5 CAHIC Latest Developments
13.5 Tecon
13.5.1 Tecon Company Information
13.5.2 Tecon Swine Vaccines Product Portfolios and Specifications
13.5.3 Tecon Swine Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Tecon Main Business Overview
13.5.5 Tecon Latest Developments
13.6 Zoetis
13.6.1 Zoetis Company Information
13.6.2 Zoetis Swine Vaccines Product Portfolios and Specifications
13.6.3 Zoetis Swine Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Zoetis Main Business Overview
13.6.5 Zoetis Latest Developments
13.7 Ceva
13.7.1 Ceva Company Information
13.7.2 Ceva Swine Vaccines Product Portfolios and Specifications
13.7.3 Ceva Swine Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Ceva Main Business Overview
13.7.5 Ceva Latest Developments
13.8 Hile Bio
13.8.1 Hile Bio Company Information
13.8.2 Hile Bio Swine Vaccines Product Portfolios and Specifications
13.8.3 Hile Bio Swine Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Hile Bio Main Business Overview
13.8.5 Hile Bio Latest Developments
13.9 Chopper Biology
13.9.1 Chopper Biology Company Information
13.9.2 Chopper Biology Swine Vaccines Product Portfolios and Specifications
13.9.3 Chopper Biology Swine Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Chopper Biology Main Business Overview
13.9.5 Chopper Biology Latest Developments
13.10 WINSUN
13.10.1 WINSUN Company Information
13.10.2 WINSUN Swine Vaccines Product Portfolios and Specifications
13.10.3 WINSUN Swine Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 WINSUN Main Business Overview
13.10.5 WINSUN Latest Developments
13.11 Hipra
13.11.1 Hipra Company Information
13.11.2 Hipra Swine Vaccines Product Portfolios and Specifications
13.11.3 Hipra Swine Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Hipra Main Business Overview
13.11.5 Hipra Latest Developments
13.12 Ringpu Biology
13.12.1 Ringpu Biology Company Information
13.12.2 Ringpu Biology Swine Vaccines Product Portfolios and Specifications
13.12.3 Ringpu Biology Swine Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Ringpu Biology Main Business Overview
13.12.5 Ringpu Biology Latest Developments
13.13 ChengDu Tecbond
13.13.1 ChengDu Tecbond Company Information
13.13.2 ChengDu Tecbond Swine Vaccines Product Portfolios and Specifications
13.13.3 ChengDu Tecbond Swine Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 ChengDu Tecbond Main Business Overview
13.13.5 ChengDu Tecbond Latest Developments
13.14 DHN
13.14.1 DHN Company Information
13.14.2 DHN Swine Vaccines Product Portfolios and Specifications
13.14.3 DHN Swine Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.14.4 DHN Main Business Overview
13.14.5 DHN Latest Developments
13.15 CAVAC
13.15.1 CAVAC Company Information
13.15.2 CAVAC Swine Vaccines Product Portfolios and Specifications
13.15.3 CAVAC Swine Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.15.4 CAVAC Main Business Overview
13.15.5 CAVAC Latest Developments
13.16 Virbac
13.16.1 Virbac Company Information
13.16.2 Virbac Swine Vaccines Product Portfolios and Specifications
13.16.3 Virbac Swine Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.16.4 Virbac Main Business Overview
13.16.5 Virbac Latest Developments
13.17 HVRI
13.17.1 HVRI Company Information
13.17.2 HVRI Swine Vaccines Product Portfolios and Specifications
13.17.3 HVRI Swine Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.17.4 HVRI Main Business Overview
13.17.5 HVRI Latest Developments
13.18 Bioveta
13.18.1 Bioveta Company Information
13.18.2 Bioveta Swine Vaccines Product Portfolios and Specifications
13.18.3 Bioveta Swine Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.18.4 Bioveta Main Business Overview
13.18.5 Bioveta Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Swine Vaccines Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Swine Vaccines by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Swine Vaccines by Country/Region, 2019, 2023 & 2030
2.2 Swine Vaccines Segment by Type
2.2.1 CSF Vaccines
2.2.2 FMD Vaccines
2.2.3 Porcine Circovirus Vaccines
2.2.4 PRRS Vaccines
2.2.5 Others
2.3 Swine Vaccines Sales by Type
2.3.1 Global Swine Vaccines Sales Market Share by Type (2019-2024)
2.3.2 Global Swine Vaccines Revenue and Market Share by Type (2019-2024)
2.3.3 Global Swine Vaccines Sale Price by Type (2019-2024)
2.4 Swine Vaccines Segment by Application
2.4.1 Government Tender
2.4.2 Market Sales
2.5 Swine Vaccines Sales by Application
2.5.1 Global Swine Vaccines Sale Market Share by Application (2019-2024)
2.5.2 Global Swine Vaccines Revenue and Market Share by Application (2019-2024)
2.5.3 Global Swine Vaccines Sale Price by Application (2019-2024)
3 GLOBAL SWINE VACCINES BY COMPANY
3.1 Global Swine Vaccines Breakdown Data by Company
3.1.1 Global Swine Vaccines Annual Sales by Company (2019-2024)
3.1.2 Global Swine Vaccines Sales Market Share by Company (2019-2024)
3.2 Global Swine Vaccines Annual Revenue by Company (2019-2024)
3.2.1 Global Swine Vaccines Revenue by Company (2019-2024)
3.2.2 Global Swine Vaccines Revenue Market Share by Company (2019-2024)
3.3 Global Swine Vaccines Sale Price by Company
3.4 Key Manufacturers Swine Vaccines Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Swine Vaccines Product Location Distribution
3.4.2 Players Swine Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR SWINE VACCINES BY GEOGRAPHIC REGION
4.1 World Historic Swine Vaccines Market Size by Geographic Region (2019-2024)
4.1.1 Global Swine Vaccines Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Swine Vaccines Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Swine Vaccines Market Size by Country/Region (2019-2024)
4.2.1 Global Swine Vaccines Annual Sales by Country/Region (2019-2024)
4.2.2 Global Swine Vaccines Annual Revenue by Country/Region (2019-2024)
4.3 Americas Swine Vaccines Sales Growth
4.4 APAC Swine Vaccines Sales Growth
4.5 Europe Swine Vaccines Sales Growth
4.6 Middle East & Africa Swine Vaccines Sales Growth
5 AMERICAS
5.1 Americas Swine Vaccines Sales by Country
5.1.1 Americas Swine Vaccines Sales by Country (2019-2024)
5.1.2 Americas Swine Vaccines Revenue by Country (2019-2024)
5.2 Americas Swine Vaccines Sales by Type
5.3 Americas Swine Vaccines Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Swine Vaccines Sales by Region
6.1.1 APAC Swine Vaccines Sales by Region (2019-2024)
6.1.2 APAC Swine Vaccines Revenue by Region (2019-2024)
6.2 APAC Swine Vaccines Sales by Type
6.3 APAC Swine Vaccines Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Swine Vaccines by Country
7.1.1 Europe Swine Vaccines Sales by Country (2019-2024)
7.1.2 Europe Swine Vaccines Revenue by Country (2019-2024)
7.2 Europe Swine Vaccines Sales by Type
7.3 Europe Swine Vaccines Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Swine Vaccines by Country
8.1.1 Middle East & Africa Swine Vaccines Sales by Country (2019-2024)
8.1.2 Middle East & Africa Swine Vaccines Revenue by Country (2019-2024)
8.2 Middle East & Africa Swine Vaccines Sales by Type
8.3 Middle East & Africa Swine Vaccines Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Swine Vaccines
10.3 Manufacturing Process Analysis of Swine Vaccines
10.4 Industry Chain Structure of Swine Vaccines
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Swine Vaccines Distributors
11.3 Swine Vaccines Customer
12 WORLD FORECAST REVIEW FOR SWINE VACCINES BY GEOGRAPHIC REGION
12.1 Global Swine Vaccines Market Size Forecast by Region
12.1.1 Global Swine Vaccines Forecast by Region (2025-2030)
12.1.2 Global Swine Vaccines Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Swine Vaccines Forecast by Type
12.7 Global Swine Vaccines Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck Swine Vaccines Product Portfolios and Specifications
13.1.3 Merck Swine Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 Boehringer Ingelheim
13.2.1 Boehringer Ingelheim Company Information
13.2.2 Boehringer Ingelheim Swine Vaccines Product Portfolios and Specifications
13.2.3 Boehringer Ingelheim Swine Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Boehringer Ingelheim Main Business Overview
13.2.5 Boehringer Ingelheim Latest Developments
13.3 Jinyu Bio-Technology
13.3.1 Jinyu Bio-Technology Company Information
13.3.2 Jinyu Bio-Technology Swine Vaccines Product Portfolios and Specifications
13.3.3 Jinyu Bio-Technology Swine Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Jinyu Bio-Technology Main Business Overview
13.3.5 Jinyu Bio-Technology Latest Developments
13.4 CAHIC
13.4.1 CAHIC Company Information
13.4.2 CAHIC Swine Vaccines Product Portfolios and Specifications
13.4.3 CAHIC Swine Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 CAHIC Main Business Overview
13.4.5 CAHIC Latest Developments
13.5 Tecon
13.5.1 Tecon Company Information
13.5.2 Tecon Swine Vaccines Product Portfolios and Specifications
13.5.3 Tecon Swine Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Tecon Main Business Overview
13.5.5 Tecon Latest Developments
13.6 Zoetis
13.6.1 Zoetis Company Information
13.6.2 Zoetis Swine Vaccines Product Portfolios and Specifications
13.6.3 Zoetis Swine Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Zoetis Main Business Overview
13.6.5 Zoetis Latest Developments
13.7 Ceva
13.7.1 Ceva Company Information
13.7.2 Ceva Swine Vaccines Product Portfolios and Specifications
13.7.3 Ceva Swine Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Ceva Main Business Overview
13.7.5 Ceva Latest Developments
13.8 Hile Bio
13.8.1 Hile Bio Company Information
13.8.2 Hile Bio Swine Vaccines Product Portfolios and Specifications
13.8.3 Hile Bio Swine Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Hile Bio Main Business Overview
13.8.5 Hile Bio Latest Developments
13.9 Chopper Biology
13.9.1 Chopper Biology Company Information
13.9.2 Chopper Biology Swine Vaccines Product Portfolios and Specifications
13.9.3 Chopper Biology Swine Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Chopper Biology Main Business Overview
13.9.5 Chopper Biology Latest Developments
13.10 WINSUN
13.10.1 WINSUN Company Information
13.10.2 WINSUN Swine Vaccines Product Portfolios and Specifications
13.10.3 WINSUN Swine Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 WINSUN Main Business Overview
13.10.5 WINSUN Latest Developments
13.11 Hipra
13.11.1 Hipra Company Information
13.11.2 Hipra Swine Vaccines Product Portfolios and Specifications
13.11.3 Hipra Swine Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Hipra Main Business Overview
13.11.5 Hipra Latest Developments
13.12 Ringpu Biology
13.12.1 Ringpu Biology Company Information
13.12.2 Ringpu Biology Swine Vaccines Product Portfolios and Specifications
13.12.3 Ringpu Biology Swine Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Ringpu Biology Main Business Overview
13.12.5 Ringpu Biology Latest Developments
13.13 ChengDu Tecbond
13.13.1 ChengDu Tecbond Company Information
13.13.2 ChengDu Tecbond Swine Vaccines Product Portfolios and Specifications
13.13.3 ChengDu Tecbond Swine Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 ChengDu Tecbond Main Business Overview
13.13.5 ChengDu Tecbond Latest Developments
13.14 DHN
13.14.1 DHN Company Information
13.14.2 DHN Swine Vaccines Product Portfolios and Specifications
13.14.3 DHN Swine Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.14.4 DHN Main Business Overview
13.14.5 DHN Latest Developments
13.15 CAVAC
13.15.1 CAVAC Company Information
13.15.2 CAVAC Swine Vaccines Product Portfolios and Specifications
13.15.3 CAVAC Swine Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.15.4 CAVAC Main Business Overview
13.15.5 CAVAC Latest Developments
13.16 Virbac
13.16.1 Virbac Company Information
13.16.2 Virbac Swine Vaccines Product Portfolios and Specifications
13.16.3 Virbac Swine Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.16.4 Virbac Main Business Overview
13.16.5 Virbac Latest Developments
13.17 HVRI
13.17.1 HVRI Company Information
13.17.2 HVRI Swine Vaccines Product Portfolios and Specifications
13.17.3 HVRI Swine Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.17.4 HVRI Main Business Overview
13.17.5 HVRI Latest Developments
13.18 Bioveta
13.18.1 Bioveta Company Information
13.18.2 Bioveta Swine Vaccines Product Portfolios and Specifications
13.18.3 Bioveta Swine Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.18.4 Bioveta Main Business Overview
13.18.5 Bioveta Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Swine Vaccines Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Swine Vaccines Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of CSF Vaccines
Table 4. Major Players of FMD Vaccines
Table 5. Major Players of Porcine Circovirus Vaccines
Table 6. Major Players of PRRS Vaccines
Table 7. Major Players of Others
Table 8. Global Swine Vaccines Sales by Type (2019-2024) & (M Doses)
Table 9. Global Swine Vaccines Sales Market Share by Type (2019-2024)
Table 10. Global Swine Vaccines Revenue by Type (2019-2024) & ($ million)
Table 11. Global Swine Vaccines Revenue Market Share by Type (2019-2024)
Table 12. Global Swine Vaccines Sale Price by Type (2019-2024) & (USD/K Doses)
Table 13. Global Swine Vaccines Sales by Application (2019-2024) & (M Doses)
Table 14. Global Swine Vaccines Sales Market Share by Application (2019-2024)
Table 15. Global Swine Vaccines Revenue by Application (2019-2024)
Table 16. Global Swine Vaccines Revenue Market Share by Application (2019-2024)
Table 17. Global Swine Vaccines Sale Price by Application (2019-2024) & (USD/K Doses)
Table 18. Global Swine Vaccines Sales by Company (2019-2024) & (M Doses)
Table 19. Global Swine Vaccines Sales Market Share by Company (2019-2024)
Table 20. Global Swine Vaccines Revenue by Company (2019-2024) ($ Millions)
Table 21. Global Swine Vaccines Revenue Market Share by Company (2019-2024)
Table 22. Global Swine Vaccines Sale Price by Company (2019-2024) & (USD/K Doses)
Table 23. Key Manufacturers Swine Vaccines Producing Area Distribution and Sales Area
Table 24. Players Swine Vaccines Products Offered
Table 25. Swine Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Swine Vaccines Sales by Geographic Region (2019-2024) & (M Doses)
Table 29. Global Swine Vaccines Sales Market Share Geographic Region (2019-2024)
Table 30. Global Swine Vaccines Revenue by Geographic Region (2019-2024) & ($ millions)
Table 31. Global Swine Vaccines Revenue Market Share by Geographic Region (2019-2024)
Table 32. Global Swine Vaccines Sales by Country/Region (2019-2024) & (M Doses)
Table 33. Global Swine Vaccines Sales Market Share by Country/Region (2019-2024)
Table 34. Global Swine Vaccines Revenue by Country/Region (2019-2024) & ($ millions)
Table 35. Global Swine Vaccines Revenue Market Share by Country/Region (2019-2024)
Table 36. Americas Swine Vaccines Sales by Country (2019-2024) & (M Doses)
Table 37. Americas Swine Vaccines Sales Market Share by Country (2019-2024)
Table 38. Americas Swine Vaccines Revenue by Country (2019-2024) & ($ Millions)
Table 39. Americas Swine Vaccines Revenue Market Share by Country (2019-2024)
Table 40. Americas Swine Vaccines Sales by Type (2019-2024) & (M Doses)
Table 41. Americas Swine Vaccines Sales by Application (2019-2024) & (M Doses)
Table 42. APAC Swine Vaccines Sales by Region (2019-2024) & (M Doses)
Table 43. APAC Swine Vaccines Sales Market Share by Region (2019-2024)
Table 44. APAC Swine Vaccines Revenue by Region (2019-2024) & ($ Millions)
Table 45. APAC Swine Vaccines Revenue Market Share by Region (2019-2024)
Table 46. APAC Swine Vaccines Sales by Type (2019-2024) & (M Doses)
Table 47. APAC Swine Vaccines Sales by Application (2019-2024) & (M Doses)
Table 48. Europe Swine Vaccines Sales by Country (2019-2024) & (M Doses)
Table 49. Europe Swine Vaccines Sales Market Share by Country (2019-2024)
Table 50. Europe Swine Vaccines Revenue by Country (2019-2024) & ($ Millions)
Table 51. Europe Swine Vaccines Revenue Market Share by Country (2019-2024)
Table 52. Europe Swine Vaccines Sales by Type (2019-2024) & (M Doses)
Table 53. Europe Swine Vaccines Sales by Application (2019-2024) & (M Doses)
Table 54. Middle East & Africa Swine Vaccines Sales by Country (2019-2024) & (M Doses)
Table 55. Middle East & Africa Swine Vaccines Sales Market Share by Country (2019-2024)
Table 56. Middle East & Africa Swine Vaccines Revenue by Country (2019-2024) & ($ Millions)
Table 57. Middle East & Africa Swine Vaccines Revenue Market Share by Country (2019-2024)
Table 58. Middle East & Africa Swine Vaccines Sales by Type (2019-2024) & (M Doses)
Table 59. Middle East & Africa Swine Vaccines Sales by Application (2019-2024) & (M Doses)
Table 60. Key Market Drivers & Growth Opportunities of Swine Vaccines
Table 61. Key Market Challenges & Risks of Swine Vaccines
Table 62. Key Industry Trends of Swine Vaccines
Table 63. Swine Vaccines Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. Swine Vaccines Distributors List
Table 66. Swine Vaccines Customer List
Table 67. Global Swine Vaccines Sales Forecast by Region (2025-2030) & (M Doses)
Table 68. Global Swine Vaccines Revenue Forecast by Region (2025-2030) & ($ millions)
Table 69. Americas Swine Vaccines Sales Forecast by Country (2025-2030) & (M Doses)
Table 70. Americas Swine Vaccines Revenue Forecast by Country (2025-2030) & ($ millions)
Table 71. APAC Swine Vaccines Sales Forecast by Region (2025-2030) & (M Doses)
Table 72. APAC Swine Vaccines Revenue Forecast by Region (2025-2030) & ($ millions)
Table 73. Europe Swine Vaccines Sales Forecast by Country (2025-2030) & (M Doses)
Table 74. Europe Swine Vaccines Revenue Forecast by Country (2025-2030) & ($ millions)
Table 75. Middle East & Africa Swine Vaccines Sales Forecast by Country (2025-2030) & (M Doses)
Table 76. Middle East & Africa Swine Vaccines Revenue Forecast by Country (2025-2030) & ($ millions)
Table 77. Global Swine Vaccines Sales Forecast by Type (2025-2030) & (M Doses)
Table 78. Global Swine Vaccines Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 79. Global Swine Vaccines Sales Forecast by Application (2025-2030) & (M Doses)
Table 80. Global Swine Vaccines Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 81. Merck Basic Information, Swine Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 82. Merck Swine Vaccines Product Portfolios and Specifications
Table 83. Merck Swine Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 84. Merck Main Business
Table 85. Merck Latest Developments
Table 86. Boehringer Ingelheim Basic Information, Swine Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 87. Boehringer Ingelheim Swine Vaccines Product Portfolios and Specifications
Table 88. Boehringer Ingelheim Swine Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 89. Boehringer Ingelheim Main Business
Table 90. Boehringer Ingelheim Latest Developments
Table 91. Jinyu Bio-Technology Basic Information, Swine Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 92. Jinyu Bio-Technology Swine Vaccines Product Portfolios and Specifications
Table 93. Jinyu Bio-Technology Swine Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 94. Jinyu Bio-Technology Main Business
Table 95. Jinyu Bio-Technology Latest Developments
Table 96. CAHIC Basic Information, Swine Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 97. CAHIC Swine Vaccines Product Portfolios and Specifications
Table 98. CAHIC Swine Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 99. CAHIC Main Business
Table 100. CAHIC Latest Developments
Table 101. Tecon Basic Information, Swine Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 102. Tecon Swine Vaccines Product Portfolios and Specifications
Table 103. Tecon Swine Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 104. Tecon Main Business
Table 105. Tecon Latest Developments
Table 106. Zoetis Basic Information, Swine Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 107. Zoetis Swine Vaccines Product Portfolios and Specifications
Table 108. Zoetis Swine Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 109. Zoetis Main Business
Table 110. Zoetis Latest Developments
Table 111. Ceva Basic Information, Swine Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 112. Ceva Swine Vaccines Product Portfolios and Specifications
Table 113. Ceva Swine Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 114. Ceva Main Business
Table 115. Ceva Latest Developments
Table 116. Hile Bio Basic Information, Swine Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 117. Hile Bio Swine Vaccines Product Portfolios and Specifications
Table 118. Hile Bio Swine Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 119. Hile Bio Main Business
Table 120. Hile Bio Latest Developments
Table 121. Chopper Biology Basic Information, Swine Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 122. Chopper Biology Swine Vaccines Product Portfolios and Specifications
Table 123. Chopper Biology Swine Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 124. Chopper Biology Main Business
Table 125. Chopper Biology Latest Developments
Table 126. WINSUN Basic Information, Swine Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 127. WINSUN Swine Vaccines Product Portfolios and Specifications
Table 128. WINSUN Swine Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 129. WINSUN Main Business
Table 130. WINSUN Latest Developments
Table 131. Hipra Basic Information, Swine Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 132. Hipra Swine Vaccines Product Portfolios and Specifications
Table 133. Hipra Swine Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 134. Hipra Main Business
Table 135. Hipra Latest Developments
Table 136. Ringpu Biology Basic Information, Swine Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 137. Ringpu Biology Swine Vaccines Product Portfolios and Specifications
Table 138. Ringpu Biology Swine Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 139. Ringpu Biology Main Business
Table 140. Ringpu Biology Latest Developments
Table 141. ChengDu Tecbond Basic Information, Swine Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 142. ChengDu Tecbond Swine Vaccines Product Portfolios and Specifications
Table 143. ChengDu Tecbond Swine Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 144. ChengDu Tecbond Main Business
Table 145. ChengDu Tecbond Latest Developments
Table 146. DHN Basic Information, Swine Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 147. DHN Swine Vaccines Product Portfolios and Specifications
Table 148. DHN Swine Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 149. DHN Main Business
Table 150. DHN Latest Developments
Table 151. CAVAC Basic Information, Swine Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 152. CAVAC Swine Vaccines Product Portfolios and Specifications
Table 153. CAVAC Swine Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 154. CAVAC Main Business
Table 155. CAVAC Latest Developments
Table 156. Virbac Basic Information, Swine Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 157. Virbac Swine Vaccines Product Portfolios and Specifications
Table 158. Virbac Swine Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 159. Virbac Main Business
Table 160. Virbac Latest Developments
Table 161. HVRI Basic Information, Swine Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 162. HVRI Swine Vaccines Product Portfolios and Specifications
Table 163. HVRI Swine Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 164. HVRI Main Business
Table 165. HVRI Latest Developments
Table 166. Bioveta Basic Information, Swine Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 167. Bioveta Swine Vaccines Product Portfolios and Specifications
Table 168. Bioveta Swine Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 169. Bioveta Main Business
Table 170. Bioveta Latest Developments
Table 1. Swine Vaccines Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Swine Vaccines Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of CSF Vaccines
Table 4. Major Players of FMD Vaccines
Table 5. Major Players of Porcine Circovirus Vaccines
Table 6. Major Players of PRRS Vaccines
Table 7. Major Players of Others
Table 8. Global Swine Vaccines Sales by Type (2019-2024) & (M Doses)
Table 9. Global Swine Vaccines Sales Market Share by Type (2019-2024)
Table 10. Global Swine Vaccines Revenue by Type (2019-2024) & ($ million)
Table 11. Global Swine Vaccines Revenue Market Share by Type (2019-2024)
Table 12. Global Swine Vaccines Sale Price by Type (2019-2024) & (USD/K Doses)
Table 13. Global Swine Vaccines Sales by Application (2019-2024) & (M Doses)
Table 14. Global Swine Vaccines Sales Market Share by Application (2019-2024)
Table 15. Global Swine Vaccines Revenue by Application (2019-2024)
Table 16. Global Swine Vaccines Revenue Market Share by Application (2019-2024)
Table 17. Global Swine Vaccines Sale Price by Application (2019-2024) & (USD/K Doses)
Table 18. Global Swine Vaccines Sales by Company (2019-2024) & (M Doses)
Table 19. Global Swine Vaccines Sales Market Share by Company (2019-2024)
Table 20. Global Swine Vaccines Revenue by Company (2019-2024) ($ Millions)
Table 21. Global Swine Vaccines Revenue Market Share by Company (2019-2024)
Table 22. Global Swine Vaccines Sale Price by Company (2019-2024) & (USD/K Doses)
Table 23. Key Manufacturers Swine Vaccines Producing Area Distribution and Sales Area
Table 24. Players Swine Vaccines Products Offered
Table 25. Swine Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Swine Vaccines Sales by Geographic Region (2019-2024) & (M Doses)
Table 29. Global Swine Vaccines Sales Market Share Geographic Region (2019-2024)
Table 30. Global Swine Vaccines Revenue by Geographic Region (2019-2024) & ($ millions)
Table 31. Global Swine Vaccines Revenue Market Share by Geographic Region (2019-2024)
Table 32. Global Swine Vaccines Sales by Country/Region (2019-2024) & (M Doses)
Table 33. Global Swine Vaccines Sales Market Share by Country/Region (2019-2024)
Table 34. Global Swine Vaccines Revenue by Country/Region (2019-2024) & ($ millions)
Table 35. Global Swine Vaccines Revenue Market Share by Country/Region (2019-2024)
Table 36. Americas Swine Vaccines Sales by Country (2019-2024) & (M Doses)
Table 37. Americas Swine Vaccines Sales Market Share by Country (2019-2024)
Table 38. Americas Swine Vaccines Revenue by Country (2019-2024) & ($ Millions)
Table 39. Americas Swine Vaccines Revenue Market Share by Country (2019-2024)
Table 40. Americas Swine Vaccines Sales by Type (2019-2024) & (M Doses)
Table 41. Americas Swine Vaccines Sales by Application (2019-2024) & (M Doses)
Table 42. APAC Swine Vaccines Sales by Region (2019-2024) & (M Doses)
Table 43. APAC Swine Vaccines Sales Market Share by Region (2019-2024)
Table 44. APAC Swine Vaccines Revenue by Region (2019-2024) & ($ Millions)
Table 45. APAC Swine Vaccines Revenue Market Share by Region (2019-2024)
Table 46. APAC Swine Vaccines Sales by Type (2019-2024) & (M Doses)
Table 47. APAC Swine Vaccines Sales by Application (2019-2024) & (M Doses)
Table 48. Europe Swine Vaccines Sales by Country (2019-2024) & (M Doses)
Table 49. Europe Swine Vaccines Sales Market Share by Country (2019-2024)
Table 50. Europe Swine Vaccines Revenue by Country (2019-2024) & ($ Millions)
Table 51. Europe Swine Vaccines Revenue Market Share by Country (2019-2024)
Table 52. Europe Swine Vaccines Sales by Type (2019-2024) & (M Doses)
Table 53. Europe Swine Vaccines Sales by Application (2019-2024) & (M Doses)
Table 54. Middle East & Africa Swine Vaccines Sales by Country (2019-2024) & (M Doses)
Table 55. Middle East & Africa Swine Vaccines Sales Market Share by Country (2019-2024)
Table 56. Middle East & Africa Swine Vaccines Revenue by Country (2019-2024) & ($ Millions)
Table 57. Middle East & Africa Swine Vaccines Revenue Market Share by Country (2019-2024)
Table 58. Middle East & Africa Swine Vaccines Sales by Type (2019-2024) & (M Doses)
Table 59. Middle East & Africa Swine Vaccines Sales by Application (2019-2024) & (M Doses)
Table 60. Key Market Drivers & Growth Opportunities of Swine Vaccines
Table 61. Key Market Challenges & Risks of Swine Vaccines
Table 62. Key Industry Trends of Swine Vaccines
Table 63. Swine Vaccines Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. Swine Vaccines Distributors List
Table 66. Swine Vaccines Customer List
Table 67. Global Swine Vaccines Sales Forecast by Region (2025-2030) & (M Doses)
Table 68. Global Swine Vaccines Revenue Forecast by Region (2025-2030) & ($ millions)
Table 69. Americas Swine Vaccines Sales Forecast by Country (2025-2030) & (M Doses)
Table 70. Americas Swine Vaccines Revenue Forecast by Country (2025-2030) & ($ millions)
Table 71. APAC Swine Vaccines Sales Forecast by Region (2025-2030) & (M Doses)
Table 72. APAC Swine Vaccines Revenue Forecast by Region (2025-2030) & ($ millions)
Table 73. Europe Swine Vaccines Sales Forecast by Country (2025-2030) & (M Doses)
Table 74. Europe Swine Vaccines Revenue Forecast by Country (2025-2030) & ($ millions)
Table 75. Middle East & Africa Swine Vaccines Sales Forecast by Country (2025-2030) & (M Doses)
Table 76. Middle East & Africa Swine Vaccines Revenue Forecast by Country (2025-2030) & ($ millions)
Table 77. Global Swine Vaccines Sales Forecast by Type (2025-2030) & (M Doses)
Table 78. Global Swine Vaccines Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 79. Global Swine Vaccines Sales Forecast by Application (2025-2030) & (M Doses)
Table 80. Global Swine Vaccines Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 81. Merck Basic Information, Swine Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 82. Merck Swine Vaccines Product Portfolios and Specifications
Table 83. Merck Swine Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 84. Merck Main Business
Table 85. Merck Latest Developments
Table 86. Boehringer Ingelheim Basic Information, Swine Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 87. Boehringer Ingelheim Swine Vaccines Product Portfolios and Specifications
Table 88. Boehringer Ingelheim Swine Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 89. Boehringer Ingelheim Main Business
Table 90. Boehringer Ingelheim Latest Developments
Table 91. Jinyu Bio-Technology Basic Information, Swine Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 92. Jinyu Bio-Technology Swine Vaccines Product Portfolios and Specifications
Table 93. Jinyu Bio-Technology Swine Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 94. Jinyu Bio-Technology Main Business
Table 95. Jinyu Bio-Technology Latest Developments
Table 96. CAHIC Basic Information, Swine Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 97. CAHIC Swine Vaccines Product Portfolios and Specifications
Table 98. CAHIC Swine Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 99. CAHIC Main Business
Table 100. CAHIC Latest Developments
Table 101. Tecon Basic Information, Swine Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 102. Tecon Swine Vaccines Product Portfolios and Specifications
Table 103. Tecon Swine Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 104. Tecon Main Business
Table 105. Tecon Latest Developments
Table 106. Zoetis Basic Information, Swine Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 107. Zoetis Swine Vaccines Product Portfolios and Specifications
Table 108. Zoetis Swine Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 109. Zoetis Main Business
Table 110. Zoetis Latest Developments
Table 111. Ceva Basic Information, Swine Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 112. Ceva Swine Vaccines Product Portfolios and Specifications
Table 113. Ceva Swine Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 114. Ceva Main Business
Table 115. Ceva Latest Developments
Table 116. Hile Bio Basic Information, Swine Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 117. Hile Bio Swine Vaccines Product Portfolios and Specifications
Table 118. Hile Bio Swine Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 119. Hile Bio Main Business
Table 120. Hile Bio Latest Developments
Table 121. Chopper Biology Basic Information, Swine Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 122. Chopper Biology Swine Vaccines Product Portfolios and Specifications
Table 123. Chopper Biology Swine Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 124. Chopper Biology Main Business
Table 125. Chopper Biology Latest Developments
Table 126. WINSUN Basic Information, Swine Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 127. WINSUN Swine Vaccines Product Portfolios and Specifications
Table 128. WINSUN Swine Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 129. WINSUN Main Business
Table 130. WINSUN Latest Developments
Table 131. Hipra Basic Information, Swine Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 132. Hipra Swine Vaccines Product Portfolios and Specifications
Table 133. Hipra Swine Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 134. Hipra Main Business
Table 135. Hipra Latest Developments
Table 136. Ringpu Biology Basic Information, Swine Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 137. Ringpu Biology Swine Vaccines Product Portfolios and Specifications
Table 138. Ringpu Biology Swine Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 139. Ringpu Biology Main Business
Table 140. Ringpu Biology Latest Developments
Table 141. ChengDu Tecbond Basic Information, Swine Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 142. ChengDu Tecbond Swine Vaccines Product Portfolios and Specifications
Table 143. ChengDu Tecbond Swine Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 144. ChengDu Tecbond Main Business
Table 145. ChengDu Tecbond Latest Developments
Table 146. DHN Basic Information, Swine Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 147. DHN Swine Vaccines Product Portfolios and Specifications
Table 148. DHN Swine Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 149. DHN Main Business
Table 150. DHN Latest Developments
Table 151. CAVAC Basic Information, Swine Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 152. CAVAC Swine Vaccines Product Portfolios and Specifications
Table 153. CAVAC Swine Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 154. CAVAC Main Business
Table 155. CAVAC Latest Developments
Table 156. Virbac Basic Information, Swine Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 157. Virbac Swine Vaccines Product Portfolios and Specifications
Table 158. Virbac Swine Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 159. Virbac Main Business
Table 160. Virbac Latest Developments
Table 161. HVRI Basic Information, Swine Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 162. HVRI Swine Vaccines Product Portfolios and Specifications
Table 163. HVRI Swine Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 164. HVRI Main Business
Table 165. HVRI Latest Developments
Table 166. Bioveta Basic Information, Swine Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 167. Bioveta Swine Vaccines Product Portfolios and Specifications
Table 168. Bioveta Swine Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 169. Bioveta Main Business
Table 170. Bioveta Latest Developments
LIST OF FIGURES
Figure 1. Picture of Swine Vaccines
Figure 2. Swine Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Swine Vaccines Sales Growth Rate 2019-2030 (M Doses)
Figure 7. Global Swine Vaccines Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Swine Vaccines Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of CSF Vaccines
Figure 10. Product Picture of FMD Vaccines
Figure 11. Product Picture of Porcine Circovirus Vaccines
Figure 12. Product Picture of PRRS Vaccines
Figure 13. Product Picture of Others
Figure 14. Global Swine Vaccines Sales Market Share by Type in 2023
Figure 15. Global Swine Vaccines Revenue Market Share by Type (2019-2024)
Figure 16. Swine Vaccines Consumed in Government Tender
Figure 17. Global Swine Vaccines Market: Government Tender (2019-2024) & (M Doses)
Figure 18. Swine Vaccines Consumed in Market Sales
Figure 19. Global Swine Vaccines Market: Market Sales (2019-2024) & (M Doses)
Figure 20. Global Swine Vaccines Sales Market Share by Application (2023)
Figure 21. Global Swine Vaccines Revenue Market Share by Application in 2023
Figure 22. Swine Vaccines Sales Market by Company in 2023 (M Doses)
Figure 23. Global Swine Vaccines Sales Market Share by Company in 2023
Figure 24. Swine Vaccines Revenue Market by Company in 2023 ($ Million)
Figure 25. Global Swine Vaccines Revenue Market Share by Company in 2023
Figure 26. Global Swine Vaccines Sales Market Share by Geographic Region (2019-2024)
Figure 27. Global Swine Vaccines Revenue Market Share by Geographic Region in 2023
Figure 28. Americas Swine Vaccines Sales 2019-2024 (M Doses)
Figure 29. Americas Swine Vaccines Revenue 2019-2024 ($ Millions)
Figure 30. APAC Swine Vaccines Sales 2019-2024 (M Doses)
Figure 31. APAC Swine Vaccines Revenue 2019-2024 ($ Millions)
Figure 32. Europe Swine Vaccines Sales 2019-2024 (M Doses)
Figure 33. Europe Swine Vaccines Revenue 2019-2024 ($ Millions)
Figure 34. Middle East & Africa Swine Vaccines Sales 2019-2024 (M Doses)
Figure 35. Middle East & Africa Swine Vaccines Revenue 2019-2024 ($ Millions)
Figure 36. Americas Swine Vaccines Sales Market Share by Country in 2023
Figure 37. Americas Swine Vaccines Revenue Market Share by Country in 2023
Figure 38. Americas Swine Vaccines Sales Market Share by Type (2019-2024)
Figure 39. Americas Swine Vaccines Sales Market Share by Application (2019-2024)
Figure 40. United States Swine Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 41. Canada Swine Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 42. Mexico Swine Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 43. Brazil Swine Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 44. APAC Swine Vaccines Sales Market Share by Region in 2023
Figure 45. APAC Swine Vaccines Revenue Market Share by Regions in 2023
Figure 46. APAC Swine Vaccines Sales Market Share by Type (2019-2024)
Figure 47. APAC Swine Vaccines Sales Market Share by Application (2019-2024)
Figure 48. China Swine Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 49. Japan Swine Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 50. South Korea Swine Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 51. Southeast Asia Swine Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 52. India Swine Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 53. Australia Swine Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 54. China Taiwan Swine Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 55. Europe Swine Vaccines Sales Market Share by Country in 2023
Figure 56. Europe Swine Vaccines Revenue Market Share by Country in 2023
Figure 57. Europe Swine Vaccines Sales Market Share by Type (2019-2024)
Figure 58. Europe Swine Vaccines Sales Market Share by Application (2019-2024)
Figure 59. Germany Swine Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 60. France Swine Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 61. UK Swine Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 62. Italy Swine Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 63. Russia Swine Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 64. Middle East & Africa Swine Vaccines Sales Market Share by Country in 2023
Figure 65. Middle East & Africa Swine Vaccines Revenue Market Share by Country in 2023
Figure 66. Middle East & Africa Swine Vaccines Sales Market Share by Type (2019-2024)
Figure 67. Middle East & Africa Swine Vaccines Sales Market Share by Application (2019-2024)
Figure 68. Egypt Swine Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 69. South Africa Swine Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 70. Israel Swine Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 71. Turkey Swine Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 72. GCC Country Swine Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 73. Manufacturing Cost Structure Analysis of Swine Vaccines in 2023
Figure 74. Manufacturing Process Analysis of Swine Vaccines
Figure 75. Industry Chain Structure of Swine Vaccines
Figure 76. Channels of Distribution
Figure 77. Global Swine Vaccines Sales Market Forecast by Region (2025-2030)
Figure 78. Global Swine Vaccines Revenue Market Share Forecast by Region (2025-2030)
Figure 79. Global Swine Vaccines Sales Market Share Forecast by Type (2025-2030)
Figure 80. Global Swine Vaccines Revenue Market Share Forecast by Type (2025-2030)
Figure 81. Global Swine Vaccines Sales Market Share Forecast by Application (2025-2030)
Figure 82. Global Swine Vaccines Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of Swine Vaccines
Figure 2. Swine Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Swine Vaccines Sales Growth Rate 2019-2030 (M Doses)
Figure 7. Global Swine Vaccines Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Swine Vaccines Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of CSF Vaccines
Figure 10. Product Picture of FMD Vaccines
Figure 11. Product Picture of Porcine Circovirus Vaccines
Figure 12. Product Picture of PRRS Vaccines
Figure 13. Product Picture of Others
Figure 14. Global Swine Vaccines Sales Market Share by Type in 2023
Figure 15. Global Swine Vaccines Revenue Market Share by Type (2019-2024)
Figure 16. Swine Vaccines Consumed in Government Tender
Figure 17. Global Swine Vaccines Market: Government Tender (2019-2024) & (M Doses)
Figure 18. Swine Vaccines Consumed in Market Sales
Figure 19. Global Swine Vaccines Market: Market Sales (2019-2024) & (M Doses)
Figure 20. Global Swine Vaccines Sales Market Share by Application (2023)
Figure 21. Global Swine Vaccines Revenue Market Share by Application in 2023
Figure 22. Swine Vaccines Sales Market by Company in 2023 (M Doses)
Figure 23. Global Swine Vaccines Sales Market Share by Company in 2023
Figure 24. Swine Vaccines Revenue Market by Company in 2023 ($ Million)
Figure 25. Global Swine Vaccines Revenue Market Share by Company in 2023
Figure 26. Global Swine Vaccines Sales Market Share by Geographic Region (2019-2024)
Figure 27. Global Swine Vaccines Revenue Market Share by Geographic Region in 2023
Figure 28. Americas Swine Vaccines Sales 2019-2024 (M Doses)
Figure 29. Americas Swine Vaccines Revenue 2019-2024 ($ Millions)
Figure 30. APAC Swine Vaccines Sales 2019-2024 (M Doses)
Figure 31. APAC Swine Vaccines Revenue 2019-2024 ($ Millions)
Figure 32. Europe Swine Vaccines Sales 2019-2024 (M Doses)
Figure 33. Europe Swine Vaccines Revenue 2019-2024 ($ Millions)
Figure 34. Middle East & Africa Swine Vaccines Sales 2019-2024 (M Doses)
Figure 35. Middle East & Africa Swine Vaccines Revenue 2019-2024 ($ Millions)
Figure 36. Americas Swine Vaccines Sales Market Share by Country in 2023
Figure 37. Americas Swine Vaccines Revenue Market Share by Country in 2023
Figure 38. Americas Swine Vaccines Sales Market Share by Type (2019-2024)
Figure 39. Americas Swine Vaccines Sales Market Share by Application (2019-2024)
Figure 40. United States Swine Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 41. Canada Swine Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 42. Mexico Swine Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 43. Brazil Swine Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 44. APAC Swine Vaccines Sales Market Share by Region in 2023
Figure 45. APAC Swine Vaccines Revenue Market Share by Regions in 2023
Figure 46. APAC Swine Vaccines Sales Market Share by Type (2019-2024)
Figure 47. APAC Swine Vaccines Sales Market Share by Application (2019-2024)
Figure 48. China Swine Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 49. Japan Swine Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 50. South Korea Swine Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 51. Southeast Asia Swine Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 52. India Swine Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 53. Australia Swine Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 54. China Taiwan Swine Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 55. Europe Swine Vaccines Sales Market Share by Country in 2023
Figure 56. Europe Swine Vaccines Revenue Market Share by Country in 2023
Figure 57. Europe Swine Vaccines Sales Market Share by Type (2019-2024)
Figure 58. Europe Swine Vaccines Sales Market Share by Application (2019-2024)
Figure 59. Germany Swine Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 60. France Swine Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 61. UK Swine Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 62. Italy Swine Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 63. Russia Swine Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 64. Middle East & Africa Swine Vaccines Sales Market Share by Country in 2023
Figure 65. Middle East & Africa Swine Vaccines Revenue Market Share by Country in 2023
Figure 66. Middle East & Africa Swine Vaccines Sales Market Share by Type (2019-2024)
Figure 67. Middle East & Africa Swine Vaccines Sales Market Share by Application (2019-2024)
Figure 68. Egypt Swine Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 69. South Africa Swine Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 70. Israel Swine Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 71. Turkey Swine Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 72. GCC Country Swine Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 73. Manufacturing Cost Structure Analysis of Swine Vaccines in 2023
Figure 74. Manufacturing Process Analysis of Swine Vaccines
Figure 75. Industry Chain Structure of Swine Vaccines
Figure 76. Channels of Distribution
Figure 77. Global Swine Vaccines Sales Market Forecast by Region (2025-2030)
Figure 78. Global Swine Vaccines Revenue Market Share Forecast by Region (2025-2030)
Figure 79. Global Swine Vaccines Sales Market Share Forecast by Type (2025-2030)
Figure 80. Global Swine Vaccines Revenue Market Share Forecast by Type (2025-2030)
Figure 81. Global Swine Vaccines Sales Market Share Forecast by Application (2025-2030)
Figure 82. Global Swine Vaccines Revenue Market Share Forecast by Application (2025-2030)
